Clinical Trials for Mesothelioma Patients: Electronic Tool to Record Cancer Symptoms
Read about a current clinical trial being conducted utilizing a hand-held electronic tool for patients with advanced cancer or malignant mesothelioma. Please note: this information is provided by Weitz & Luxenberg for informational purposes only. This trial is currently only being conducted in Switzerland.
Rationale:
A hand-held electronic tool used to monitor symptoms and assess quality of life may improve communication between patients and their doctors and improve the ability to plan treatment for patients with advanced cancer receiving palliative care. It is not yet known whether symptoms are better controlled with or without use of this electronic tool.
Purpose:
This randomized phase III trial is studying an electronic tool to see how well it records cancer symptoms in patients with advanced cancer receiving palliative care.
Requisite Conditions:
Phase III Cancer
Procedures: cognitive assessment; counseling; fatigue assessment and management; psychosocial assessment and care; quality-of-life assessment
Study Type and Design:
Interventional; Health Services Research, Randomized, Active Control
Official Title:
E-MOSAIC: A Multicenter Randomized Controlled Phase III Study of Longitudinal Electronic Monitoring of Symptoms and Syndromes Associated With Advanced Cancer in Patients Receiving Anticancer Treatment in Palliative Intention
Courtesy of ClinicalTrials.gov, a service of the U.S. National Institutes of Health


Study outline for use of electronic tool by mesothelioma patients